Search

Your search keyword '"Visentini, Marcella"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Visentini, Marcella" Remove constraint Author: "Visentini, Marcella" Publisher elsevier bv Remove constraint Publisher: elsevier bv
26 results on '"Visentini, Marcella"'

Search Results

1. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

2. Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates

3. Platelets from patients with decompensated cirrhosis display pro-inflammatory features

4. Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2

6. Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases

7. Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID‐19 vaccine

8. Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature

9. COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies

10. Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report

11. Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups

12. Impaired Immunogenicity to COVID-19 Vaccines in Autoimmune Systemic Diseases - High Prevalence of Non-Response in Different Patients’ Subgroups

16. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies

19. DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells

20. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review

21. Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency

23. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

Catalog

Books, media, physical & digital resources